Is AIkido Pharma Inc. (AIKI) a good stock to buy now?

AIkido Pharma Inc. (NASDAQ: AIKI) is -34.82% lower on its value in year-to-date trading and has touched a low of $0.47 and a high of $5.46 in the current 52-week trading range. The AIKI stock was last observed hovering at around $0.85 in the recent trading session, with the current loss setting it -0.01%.


The 2021 Backdoor Crypto Portfolio (free)

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


At last check, trading at $0.84, the stock is 4.64% and 12.16% above its SMA20 and SMA50 respectively. However, with a current trading volume of 0.66 million and changing -0.92% at the moment leaves the stock -20.27% off its SMA200. AIKI registered -61.80% loss for a year compared to 6-month loss of -33.82%. The firm has a 50-day simple moving average (SMA 50) of $0.7718 and a 200-day simple moving average (SMA200) of $0.7979.

The stock witnessed a 16.58% gain in the last 1 month and extending the period to 3 months gives it a 38.77%, and is 1.18% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.66% over the week and 11.21% over the month.

AIkido Pharma Inc. (AIKI) has around 3 employees, a market worth around $30.45M and $0.01M in sales. Distance from 52-week low is 77.60% and -84.56% from its 52-week high.

AIkido Pharma Inc. (AIKI) Analyst Forecasts

AIkido Pharma Inc. quarterly earnings per share for the current quarter are estimated at $0.The EPS is expected to shrink by -282.90% this year.

AIkido Pharma Inc. (AIKI) Top Institutional Holders

13 institutions hold shares in AIkido Pharma Inc. (AIKI), with 1.97M shares held by insiders accounting for 5.64% while institutional investors hold 18.50% of the company’s shares. The shares outstanding are 34.92M, and float is at 26.95M with Short Float at 0.54%. Institutions hold 17.45% of the Float.

The top institutional shareholder in the company is Renaissance Technologies, LLC with over 0.21 million shares valued at $0.11 million. The investor’s holdings represent 0.60% of the AIKI Shares outstanding. As of Mar 30, 2020, the second largest holder is Two Sigma Securities, LLC with 25694.0 shares valued at $13024.0 to account for 0.07% of the shares outstanding. The other top investors are Susquehanna International Group, LLP which holds 22766.0 shares representing 0.07% and valued at over $11540.0, while Vanguard Group, Inc. (The) holds 0.06% of the shares totaling 20740.0 with a market value of $10513.0.

AIkido Pharma Inc. (AIKI) Insider Activity

A total of 0 insider transactions have happened at AIkido Pharma Inc. (AIKI) in the last six months, with sales accounting for 0 and purchases happening 0 times.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free